SAN RAMON, Calif., May 7, 2020— CooperVision is continually assessing what we can do to support customers and patients during this time. In support of essential hospital workers fighting on the front lines of the COVID-19 pandemic, CooperVision is providing U.S. eye care professionals with complimentary contact lens refills to extend to these healthcare heroes.
Through the program, essential hospital workers may receive one box of CooperVision contact lenses for each eye, including all 1-day, 2-week and monthly brands that the company manufactures, such as clariti® 1 day, MyDay®, Biofinity®, Avaira® and Proclear® brands.* They must be presently working at a hospital in the U.S. to fight COVID-19, and a current contact lens prescription is required.
“We are deeply grateful for the men and women who are working in hospitals to take care of patients stricken with COVID-19. They are enduring long hours in uncomfortable personal protective equipment and dealing with the stress of caring for the seriously ill—all while risking their own health in the process,” said Jerry Warner, President, Americas and Global Commercial Functions, CooperVision. “We’re all looking for ways to help, and at CooperVision, we can partner with eye care professionals to provide contact lenses, ensuring our front line hospital workers have the vision correction they need to do their jobs and live their lives.”
The CooperVision Essential Hospital Workers Complimentary Contact Lens Program will run through June 5th , 2020. To learn more about the program or to obtain contact lenses for eligible patients, eye care professionals must submit the application form which can be found by visiting https://coopervision.com/practitioner/ecp-viewpoints/covid-19-resources via email to CVcares@coopervision.com. Once the application is processed, the lenses will be shipped directly to the address provided for the patient. Orders via authorized distributors will not be accepted for this program.
# # #
* Does not include CooperVision MiSight® 1 day
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
firstname.lastname@example.org or +1-585-434-2148